Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies

European Journal of Surgical Oncology

Volumn 32, Issue 6, 2006, Pages 607-613

  Elias, D ^a   Raynard, B ^a   Bonnay, M ^a   Pocard, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Colorectal cancer; Cytoreductive surgery; Hyperthermia; Intraperitoneal chemotherapy; Irinotecan; Oxaliplatin; Peritoneal carcinomatosis; Peritonectomy

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; FLUOROURACIL; FOLINIC ACID; HYPOTONIC SOLUTION; IRINOTECAN; OXALIPLATIN;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHEMOSURGERY; CLINICAL TRIAL; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DIARRHEA; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG INCOMPATIBILITY; DRUG INSTILLATION; FOLLOW UP; HEATING; HEMATOLOGIC DISEASE; HUMAN; HYPERTHERMIC THERAPY; KIDNEY FAILURE; MONOTHERAPY; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; OPTIMAL DRUG DOSE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CAMPTOTHECIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; TISSUE DISTRIBUTION;

EID: 33745992966     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.03.004     Document Type: Article

References (29)

1. Elias D., Detroz B., Debaene B., Damia E., Leclercq B., Rougier P., et al. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. Hepato-Gastroenterol 41 (1994) 207-213
2. Sugarbaker P.H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14 (1998) 254-261
3. Yonemura Y., Fujimura T., Nishimura G., Falla R., Sawa T., Katayama K., et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119 (1996) 437-444
4. Elias D., Antoun A., Goharin A., El Otmany A., Puizillout J.M., and Lasser P. Research on the best chemohyperthermia technique for treatment of peritoneal carcinomatosis after complete resection. Int J Surg Invest 1 (2000) 431-439
5. Fujimoto S., Shresta R.D., Kokubun M., Kobayashi K., Kiushu S., Konna C., et al. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far advanced gastric cancer. Ann Surg 212 (1990) 592-596
6. Hamazoe R., Maeta M., and Keibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 73 (1994) 2048-2052
7. Van der Vaart P.J., van der Vange N., Zoetmulder F.A., van Goethtel A.R., van Tellingen O., ten Bokkel W.W., et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adducts formation in patients and ovarian cancer cell lines. Eur J Cancer 34 (1998) 148-154
8. Becouarn Y., Ychou M., Ducreux M., Borel C., Bertheault-Cvitkovic F., Seitz J.F., et al. Phase II trial of oxaliplatin as first line chemotherapy in metastatic colorectal cancer. J Clin Oncol 16 (1998) 2739-2744
9. Giachetti S., Perpoint B., Zidani R., Le Bail R., Faggiuolo R., Focan C., et al. Phase III multicenter randomized trial of oxaliplatin added to chronomoduled fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer. J Clin Oncol 18 (2000) 136-147
10. De Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., et al. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
11. Sugarbaker P.H., Cunliffe W., Belliveau J.F., de Bruin E., and Graves T. Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1 (1988) 66-79
12. Sugarbaker P.H., and Jablonski K.H. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 22 (1995) 124-132
13. Elias D., Gachot B., Bonvalot S., Blot F., Sabourin J.C., Ducreux M., et al. Carcinoses péritonéales traitées par exérèse complète et chimiothérapie intra-péritonéale postopératoire immédiate (CIPPI). Etude de phase II portant sur 54 malades. Gastroenterol Clin Biol 21 (1997) 181-187
14. Didkhoff T., van der Heider J., Dubbelman R., and ten Bokkel Huinink W.W. Tissue concentration of platinum after intraperitoneal cisplatin administration in patients. Proc AACR 26 (1985) 162
15. Zoetmulder F.A. Cancer cell seeding during abdominal surgery: experimental studies. In: Sugarbaker P.H. (Ed). Peritoneal carcinomatosis: principles of management (1996), Kluwer, Boston 155-162
16. Rietbroeck R.C., van de Vaart P.J., Haveman J., Blommaert F.A., Geerdink A., Bakker P.J., et al. Hyperthermia enhances the cytotoxicity and platinum-DNA adducts formation of lobaplatin and oxaliplatin in cultured SW 1573 cells. J Cancer Res Clin Oncol 123 (1997) 6-12
17. Hahn G.M. Potential for therapy of drugs and hyperthermia. Cancer Res 39 (1979) 2264-2268
18. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
19. Song C.W., Shakil A., Osborn J.L., and Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 12 (1996) 367-373
20. Elias D., Bonnay M., Puizillou J.M., Antoun S., Demirdjian S., El Otmany A., et al. Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetic and tissue distribution. Ann Oncol 13 (2002) 267-272
21. Misset JL, Gamelin E, Allain P. Pharmacokinetics, urinary and fecal excretion of oxaliplatin in cancer patients. Debiopharm Internal Report, November 1, 1995.
22. Dickson J.A. Hyperthermia and laboratory animal systems. Proc. int. symp. on cancer therapy by hyperthermia and radiation (1975), American College of Radiology, Washington, DC 105-106
23. Elias D., El Otmany A., Bonnay M., Paci A., Ducreux M., Antoun S., et al. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions, after complete resection of peritoneal carcinomatosis. Oncology 63 (2002) 346-352
24. Groose E., Walker L., and Masters J.R. The influence of osmolarity on drug cytotoxicity in vitro. Br J Cancer 54 (1986) 181-182
25. Smith E., and Brock A.P. The effect of reduced osmolarity on platinum drug cytotoxicity. Br J Cancer 59 (1989) 873-875
26. Tsujitani S., Oka A., Kondo A., Katano K., Oka S., Saito H., et al. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats. Oncology 57 (1999) 77-82
27. Elias D., Sideris L., Pocard M., Edé C., Ben Hassouna D., Ducreux M., et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 15 (2004) 781-785
28. Elias D., Blot F., El Otmany A., Antoun S., Lasser P., Boige V., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
29. Elias D., Matsuhisa T., Sideris L., Liberale G., Drouard-Troalen L., Raynard B., et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 15 (2004) 1558-1565